No country for old men: A polypill strategy to prevent dementia?

European Journal of Neurology

Volumn 16, Issue 2, 2009, Pages

  Pistoia, F ^a,b   Desideri, G ^b   Sara M ^a   Ferri, C ^b  

^a Istituto San Raffaele   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Brain aging; CADASIL; Vascular risk factors

Indexed keywords

ANTIOXIDANT; CARDIOVASCULAR AGENT; CD40 LIGAND; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SERENIC AGENT;

ALZHEIMER DISEASE; CADASIL; GLUCOSE METABOLISM; HUMAN; LETTER; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALZHEIMER DISEASE; CADASIL; DEMENTIA, VASCULAR; HUMANS; MALE; RISK FACTORS;

EID: 58349093989     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02393.x     Document Type: Letter

References (6)

1. Formichi P, Parnetti L, Radi E, Cevenini G, Dotti MT, Federico A. CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL. European Journal of Neurology 2008 15 : 1252 1255.
2. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Disease and Associated Disorders 1999 13 : S115 S123.
3. Desideri G, Cipollone F, Necozione S, et al. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role. Neurobiology of Aging 2008 29 : 348 356.
4. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 352 : 1347 1351.
5. Dufouil C, Richard F, Fiévet N, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005 64 : 1531 1538.
6. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Archives of Neurology 2007 64 : 86 92.